Case number 1:22-cv-00020
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 26, 2023 | 219 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' document production bearing bates numbers TRUL01174760 - TRUL01174792. (Higginbotham, Daniel) (Entered: 05/26/2023) (2) |
| May 19, 2023 | 217 | JOINT STIPULATION AND ORDER. Signed by Chief District Judge Thomas S Kleeh on 5/19/2023. (snc) (Entered: 05/19/2023) (4) |
| May 19, 2023 | 218 | ORDER granting 210 Motion for Leave to Appear Pro Hac Vice (Elham F. Steiner) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 5/19/2023. (snc) (Entered: 05/19/2023) (1) |
| May 18, 2023 | 216 | STIPULATION (JOINT) and ORDER by Mylan Pharmaceuticals Inc.. (O'Brien, William) (Entered: 05/18/2023) (4) |
| May 16, 2023 | 215 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' document production bearing bates numbers TRUL01173780 TRUL01174759. (Higginbotham, Daniel) (Entered: 05/16/2023) (2) |
| May 5, 2023 | 214 | ORDER GRANTING JOINT MOTION TO EXTEND ECF NO. 213 . Signed by Chief District Judge Thomas S Kleeh on 5/5/2023. (snc) (Entered: 05/05/2023) (1) |
| May 4, 2023 | 212 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (First Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-3) and Documents produced on 4.28.23). (O'Brien, William) (Entered: 05/04/2023) (2) |
| May 4, 2023 | 213 | Joint MOTION to Extend Expert Discovery Deadlines Without Other Impact on Case Schedule by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/04/2023) (Main Document) (4) |
| May 4, 2023 | 213 | Joint MOTION to Extend Expert Discovery Deadlines Without Other Impact on Case Schedule by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 05/04/2023) (Proposed Order) (1) |
| Apr 25, 2023 | 210 | MOTION for Leave to Appear Pro Hac Vice (Elham F. Steiner) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 04/25/2023) (Main Document) (3) |
| Apr 25, 2023 | 211 | Pro Hac Vice Filing fee for Elham F. Steiner: $ 200.00, receipt number WVNC003691. (snc) (Entered: 04/25/2023) (0) |
| Apr 25, 2023 | 210 | MOTION for Leave to Appear Pro Hac Vice (Elham F. Steiner) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 04/25/2023) (Proposed Order) (1) |
| Apr 24, 2023 | 208 | ORDER TO SEAL. The Court DIRECTS the Clerk of Court to file Plaintiffs Proposed Findings of Fact and Conclusions of Law [ECF No. [207-2]] and attached exhibits UNDER SEAL. Signed by Chief District Judge Thomas S Kleeh on 4/24/2023. (jb) (Entered: 04/24/2023) (1) |
| Apr 21, 2023 | 205 | Proposed Findings of Fact and Conclusions of Law on Claim Construction ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (O'Brien, William) (Entered: 04/21/2023) (23) |
| Apr 21, 2023 | 206 | Notice of Supplemental Authority Regarding Claim Construction ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1)(O'Brien, William) (Entered: 04/21/2023) (Main Document) (3) |
| Apr 21, 2023 | 206 | Notice of Supplemental Authority Regarding Claim Construction ( Other Document ) filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1)(O'Brien, William) (Entered: 04/21/2023) (Exhibit 1) (14) |
| Apr 10, 2023 | 204 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of AmbioPharms document production bearing bates numbers TRULAP00065132 TRULAP00078457. (Higginbotham, Daniel) (Entered: 04/10/2023) (2) |
| Apr 5, 2023 | 203 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Document produced on 4.4.23). (O'Brien, William) (Entered: 04/05/2023) (1) |
| Apr 4, 2023 | 202 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of AmbioPharms document production bearing bates numbers TRULAP00047797 - TRULAP00065131, by providing an electronic download link. (Higginbotham, Daniel) (Entered: 04/04/2023) (2) |
| Mar 30, 2023 | 199 | MEMORANDUM OPINION AND ORDER DENYING PLAINTIFFS' MOTIONS TO STRIKE AFFIRMATIVE DEFENSES AND FOR JUDGMENT ON THE PLEADINGS 1:22CV20, ECF NO. 103 ; 1:22CV85, ECF NO. 7 AND MOTION TO FILE SUPPLEMENTAL BRIEFING ECF NO. 151 . Signed by Chief District Judge Thomas S Kleeh on 3/30/2023. (snc) (Entered: 03/30/2023) (12) |
| Mar 30, 2023 | 200 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of AmbioPharm's document production bearding bates numbers TRULAP00000001 - TRULAP00047796 via electronic download link to counsel for Defendant. (Higginbotham, Daniel) (Entered: 03/30/2023) (2) |
| Mar 30, 2023 | 201 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Notice of Deposition of John Kirsch. (Higginbotham, Daniel) (Entered: 03/30/2023) (1) |
| Mar 29, 2023 | 196 | TRANSCRIPT of Proceedings held on 3/22/2023 before Judge Thomas S. Kleeh. Court Reporter/Transcriber Rachel Kocher, Telephone number (304) 623-7179. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days. Redaction Request due 4/19/2023. Redacted Transcript Deadline set for 5/1/2023. Release of Transcript Restriction set for 6/27/2023. (rak) (Entered: 03/29/2023) (110) |
| Mar 29, 2023 | 197 | TRANSCRIPT PURCHASE ORDER by Bausch Health Ireland Limited for proceedings held on 3/22/2023 before Judge Thomas S. Kleeh. (rak) (Entered: 03/29/2023) (1) |
| Mar 29, 2023 | 198 | TRANSCRIPT PURCHASE ORDER by Mylan Pharmaceuticals Inc. for proceedings held on 3/22/2023 before Judge Thomas S. Kleeh. (rak) (Entered: 03/29/2023) (1) |
| Mar 27, 2023 | 195 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Responses and Objections to Plaintiffs' First Set of Requests for Admission). (O'Brien, William) (Entered: 03/27/2023) (1) |
| Mar 23, 2023 | 192 | ORDER SCHEDULING DEADLINE FOR PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW. The Court hereby ORDERS proposed findings of fact and conclusions of law be filed on or before April 21, 2023. Signed by Chief District Judge Thomas S Kleeh on 3/23/2023. (snc) (Entered: 03/23/2023) (1) |
| Mar 23, 2023 | 193 | STIPULATION Regarding Authenticity and Non-Hearsay Business Record Status by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) (Entered: 03/23/2023) (4) |
| Mar 23, 2023 | 194 | STIPULATION by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) (Entered: 03/23/2023) (6) |
| Mar 22, 2023 | 188 | MINUTE ENTRY: ***NOTICE*** THE ATTACHED DOCUMENT IS NOT ACCESSIBLE. IT IS FOR STATISTICAL PURPOSES ONLY. Proceedings held before Chief District Judge Thomas S Kleeh. Markman Hearing held on 3/22/2023. (Court Reporter Rachel Kocher) (dk) (Entered: 03/22/2023) (0) |
| Mar 22, 2023 | 189 | Clerk's Exhibit List for Markman Hearing held 3/22/2023. (dk) (Entered: 03/23/2023) (0) |
| Mar 20, 2023 | 187 | *** SEALED ***PLAINTIFFS' OPENING CLAIM CONSTRUCTION BRIEF by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A to Plfs' Opening Claim Construction Brief, # 2 Exhibit 1 to Exhibit A, # 3 Exhibit 2 to Exhibit A, # 4 Exhibit 3 to Exhibit A, # 5 Exhibit 4 to Exhibit A, # 6 Exhibit 5 to Exhibit A, # 7 Exhibit 6 to Exhibit A, # 8 Exhibit 7 to Exhibit A, # 9 Exhibit 8 to Exhibit A, # 10 Exhibit 9 to Exhibit A, # 11 Exhibit 10 to Exhibit A, # 12 Exhibit 11 to Exhibit A, # 13 Exhibit 12 to Exhibit A, # 14 Exhibit 13 to Exhibit A, # 15 Exhibit 14 to Exhibit A, # 16 Exhibit 15 to Exhibit A, # 17 Exhibit 16 to Exhibit A, # 18 Exhibit 17 to Exhibit A, # 19 Exhibit 18 to Exhibit A, # 20 Exhibit 19 to Exhibit A, # 21 Exhibit 20 to Exhibit A, # 22 Exhibit 21 to Exhibit A, # 23 Exhibit 22 to Exhibit A, # 24 Exhibit 23 to Exhibit A, # 25 Exhibit 24 to Exhibit A, # 26 Exhibit 25 to Exhibit A, # 27 Exhibit 26 to Exhibit A, # 28 Exhibit 27 to Exhibit A, # 29 Exhibit 28 to Exhibit A)(Higginbotham, Daniel) Modified on 3/20/2023 to add title and term motion. (cmd). (Entered: 03/20/2023) (0) |
| Mar 9, 2023 | 186 | ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF. NO. 185 ). The Court GRANTS the motion to withdraw [ECF No. 185] of Nicole W. Stafford effective immediately. Signed by Chief District Judge Thomas S Kleeh on 3/9/2023. (dk) (Entered: 03/09/2023) (1) |
| Mar 6, 2023 | 185 | MOTION to Withdraw as Attorney (Nicole W. Stafford) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 03/06/2023) (Main Document) (2) |
| Mar 6, 2023 | 185 | MOTION to Withdraw as Attorney (Nicole W. Stafford) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 03/06/2023) (Proposed Order) (1) |
| Mar 3, 2023 | 183 | ORDER TO SEAL GRANTING 181 . The Court DIRECTS the Clerk of Court to file Plaintiffs Responsive Claim Construction Brief [ECF No. 181-2] and attached exhibits UNDER SEAL. Signed by Chief District Judge Thomas S Kleeh on 3/3/2023. (snc) (Entered: 03/03/2023) (1) |
| Mar 2, 2023 | 179 | ORDER TO SEAL. The Court finds good cause to GRANT the motion. ECF No. 178 . The Court DIRECTS the Clerk of Court to file Defendant Mylan Pharmaceuticals, Inc.'s Responsive Claim Construction Brief [ECF No. 178-1] and attached exhibits UNDER SEAL. Signed by Chief District Judge Thomas S Kleeh on 03/02/2023. (snc) (Entered: 03/02/2023) (1) |
| Mar 2, 2023 | 182 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Rule 30(b)(6)). (O'Brien, William) (Entered: 03/02/2023) (1) |
| Feb 28, 2023 | 173 | ORDER: granting 169 MOTION for Leave to Appear Pro Hac Vice (Susannah M. L. Gagnon) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 2/28/2023. (snc) (Entered: 02/28/2023) (1) |
| Feb 28, 2023 | 174 | ORDER: granting 170 Motion for Leave to Appear Pro Hac Vice (Tung-On Kong) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 2/28/2023. (snc) (Entered: 02/28/2023) (1) |
| Feb 28, 2023 | 175 | ORDER: granting 171 Motion for Leave to Appear Pro Hac Vice; (Jackson Walker) filed by Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 2/28/2023. (snc) (Entered: 02/28/2023) (1) |
| Feb 28, 2023 | 176 | ORDER: granting 166 Motion for Leave to Appear Pro Hac Vice of Kassandra M. Officer filed by Salix Pharmaceuticals, Inc, Bausch Health Ireland Limited Signed by Chief District Judge Thomas S Kleeh on 2/28/2023. (snc) (Entered: 02/28/2023) (1) |
| Feb 28, 2023 | 177 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc re 158 Certificate of Service Plaintiffs' Objections and Responses to Defendant Mylan Pharmaceuticals Inc.'s Fourth Set of Interrogatories (Nos. 5-6). (Higginbotham, Daniel) (Entered: 02/28/2023) (2) |
| Feb 24, 2023 | 167 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc Plaintiffs' First Set of Requests for Admission to Defendant. (Higginbotham, Daniel) (Entered: 02/24/2023) (2) |
| Feb 24, 2023 | 168 | Pro Hac Vice Filing fee for Kassandra M. Officer: $ 200.00, receipt number WVNC003611. (snc) (Entered: 02/24/2023) (0) |
| Feb 24, 2023 | 169 | MOTION for Leave to Appear Pro Hac Vice (Susannah M. L. Gagnon) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/24/2023) (Main Document) (3) |
| Feb 24, 2023 | 170 | MOTION for Leave to Appear Pro Hac Vice (Tung-On Kong) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/24/2023) (Main Document) (3) |
| Feb 24, 2023 | 171 | MOTION for Leave to Appear Pro Hac Vice (Jackson Walker) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/24/2023) (Main Document) (3) |
| Feb 24, 2023 | 172 | Pro Hac Vice Filing fees for J. Walker, T. Kong and S. Gagnon: $ 600.00, receipt number WVNC003612 (jss) (Entered: 02/24/2023) (0) |
| Feb 24, 2023 | 171 | MOTION for Leave to Appear Pro Hac Vice (Jackson Walker) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/24/2023) (Proposed Order) (1) |
| Feb 24, 2023 | 169 | MOTION for Leave to Appear Pro Hac Vice (Susannah M. L. Gagnon) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/24/2023) (Proposed Order) (1) |
| Feb 24, 2023 | 170 | MOTION for Leave to Appear Pro Hac Vice (Tung-On Kong) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(O'Brien, William) (Entered: 02/24/2023) (Proposed Order) (1) |
| Feb 23, 2023 | 166 | MOTION for Leave to Appear Pro Hac Vice of Kassandra M. Officer by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(Higginbotham, Daniel) (Entered: 02/23/2023) (Main Document) (5) |
| Feb 23, 2023 | 166 | MOTION for Leave to Appear Pro Hac Vice of Kassandra M. Officer by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(Higginbotham, Daniel) (Entered: 02/23/2023) (Proposed Order) (1) |
| Feb 21, 2023 | 165 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Documents produced on 2.13.23). (O'Brien, William) (Entered: 02/21/2023) (1) |
| Feb 16, 2023 | 164 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Notices of Deposition for Ananda Kuppanna; Gaddam Pullarao; Keith Meckstroth; Madhukarrao Mattapally; Palavelli Rambabu; Ruchira Sarbajna; and Suresh Babu Jayachandra. (Higginbotham, Daniel) (Entered: 02/16/2023) (2) |
| Feb 15, 2023 | 163 | ORDER granting 161 Motion for Leave to Appear pro hac vice as to Lauren J. Robinson. Signed by Chief District Judge Thomas S Kleeh on 2/15/23. (jss) (Entered: 02/15/2023) (1) |
| Feb 14, 2023 | 162 | Pro Hac Vice Filing Fee for Lauren Robinson in the amount of $200.00 paid. Receipt Number WVNC003603. (jb) (Entered: 02/14/2023) (0) |
| Feb 13, 2023 | 160 | NOTICE of Appearance by M. David Griffith, Jr on behalf of Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc (Griffith, M.) (Entered: 02/13/2023) (2) |
| Feb 13, 2023 | 161 | MOTION for Leave to Appear Pro Hac Vice of Lauren J. Robinson by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(Higginbotham, Daniel) (Entered: 02/13/2023) (Main Document) (5) |
| Feb 13, 2023 | 161 | MOTION for Leave to Appear Pro Hac Vice of Lauren J. Robinson by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(Higginbotham, Daniel) (Entered: 02/13/2023) (Proposed Order) (1) |
| Jan 27, 2023 | 158 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Fourth Set of Interrogatories to Plaintiffs (Nos. 5-6)). (O'Brien, William) (Entered: 01/27/2023) (2) |
| Jan 27, 2023 | 159 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Documents produced on 1.27.23). (O'Brien, William) (Entered: 01/27/2023) (1) |
| Jan 26, 2023 | 157 | NOTICE of Appearance by Garrett Matthew Spiker on behalf of Mylan Pharmaceuticals Inc. (Spiker, Garrett) (Entered: 01/26/2023) (2) |
| Jan 20, 2023 | 156 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Notice of Deposition of Mylan Pharmaceuticals Inc., (Nos. 1-51) Pursuant to Fed. R. Civ. P. 30(b)(6). (Higginbotham, Daniel) (Entered: 01/20/2023) (1) |
| Jan 18, 2023 | 154 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc Certifying service of Plfs' First Supplemental Responses to Def's Interrogatory No. 2; Plfs' First Supplemental Responses to Def's 3rd Interrogatories (No. 4); Responses and Objections of Non-Party Kunwar Shailubhai, Gregory Nikiforovich, Gary Jacob, Stephen Comiskey, Ron Feng, John Foss, Juncai Bai, Ruoping Zhang and Ambiopharm, Inc. to Subpoenas. (Higginbotham, Daniel) (Entered: 01/18/2023) (2) |
| Jan 18, 2023 | 155 | RESPONSE to Motion re 151 MOTION for Leave to File Plaintiffs' Supplemental Brief in Support of Motion to Strike and Dismiss, and for Judgment on the Pleadings MYLAN PHARMACEUTICALS INC.S RESPONSE TO PLAINTIFFS MOTION FOR LEAVE TO SUPPLEMENT [ECF No. 151] AND CONDITIONAL MOTION FOR LEAVE TO FILE A RESPONSIVE BRIEF filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(Copland, Gordon) (Entered: 01/18/2023) (Main Document) (3) |
| Jan 18, 2023 | 155 | RESPONSE to Motion re 151 MOTION for Leave to File Plaintiffs' Supplemental Brief in Support of Motion to Strike and Dismiss, and for Judgment on the Pleadings MYLAN PHARMACEUTICALS INC.S RESPONSE TO PLAINTIFFS MOTION FOR LEAVE TO SUPPLEMENT [ECF No. 151] AND CONDITIONAL MOTION FOR LEAVE TO FILE A RESPONSIVE BRIEF filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(Copland, Gordon) (Entered: 01/18/2023) (Proposed Order) (2) |
| Jan 13, 2023 | 150 | ORDER TO SEAL. The Court grants [ECF NO. 148 ] Motion and directs the Plaintiffs to file under seal their opening claim construction brief and attached exhibits. Signed by Chief District Judge Thomas S Kleeh on 1/13/2023. (jb) (Entered: 01/13/2023) (1) |
| Jan 13, 2023 | 151 | MOTION for Leave to File Plaintiffs' Supplemental Brief in Support of Motion to Strike and Dismiss, and for Judgment on the Pleadings by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Supplement, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Higginbotham, Daniel) (Entered: 01/13/2023) (Main Document) (3) |
| Jan 13, 2023 | 152 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (30(b)(6) Notice of Deposition to Plaintiff Bausch Health Ireland Limited). (O'Brien, William) (Entered: 01/13/2023) (2) |
| Jan 13, 2023 | 153 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (30(b)(6) Notice of Deposition to Plaintiff Salix Pharmaceuticals, Inc.). (O'Brien, William) (Entered: 01/13/2023) (2) |
| Jan 13, 2023 | 151 | MOTION for Leave to File Plaintiffs' Supplemental Brief in Support of Motion to Strike and Dismiss, and for Judgment on the Pleadings by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Supplement, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Higginbotham, Daniel) (Entered: 01/13/2023) (Supplement) (4) |
| Jan 13, 2023 | 151 | MOTION for Leave to File Plaintiffs' Supplemental Brief in Support of Motion to Strike and Dismiss, and for Judgment on the Pleadings by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Supplement, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Higginbotham, Daniel) (Entered: 01/13/2023) (Exhibit A) (25) |
| Jan 13, 2023 | 151 | MOTION for Leave to File Plaintiffs' Supplemental Brief in Support of Motion to Strike and Dismiss, and for Judgment on the Pleadings by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Supplement, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Higginbotham, Daniel) (Entered: 01/13/2023) (Exhibit B) (23) |
| Jan 13, 2023 | 151 | MOTION for Leave to File Plaintiffs' Supplemental Brief in Support of Motion to Strike and Dismiss, and for Judgment on the Pleadings by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Supplement, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Higginbotham, Daniel) (Entered: 01/13/2023) (Exhibit C) (24) |
| Jan 13, 2023 | 151 | MOTION for Leave to File Plaintiffs' Supplemental Brief in Support of Motion to Strike and Dismiss, and for Judgment on the Pleadings by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Supplement, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Higginbotham, Daniel) (Entered: 01/13/2023) (Exhibit D) (23) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Main Document) (22) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Affidavit Declaration of Graham Buckton, Ph.D.) (30) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Exhibit Ex. 1) (3) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Exhibit Ex. 2) (30) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Exhibit Ex. 3) (30) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Exhibit Ex. 4) (5) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Exhibit Ex. 5) (6) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Exhibit Ex. 6) (25) |
| Jan 12, 2023 | 149 | MEMORANDUM Defendant Mylan Pharmaceuticals Inc. Opening Claim Construction Brief by Mylan Pharmaceuticals Inc. . (Attachments: # 1 Affidavit Declaration of Graham Buckton, Ph.D., # 2 Exhibit Ex. 1, # 3 Exhibit Ex. 2, # 4 Exhibit Ex. 3, # 5 Exhibit Ex. 4, # 6 Exhibit Ex. 5, # 7 Exhibit Ex. 6, # 8 Exhibit Ex. 7)(Copland, Gordon) (Entered: 01/12/2023) (Exhibit Ex. 7) (25) |
| Dec 12, 2022 | 147 | ORDER GRANTING JOINT MOTION TO EXTEND (ECF. NO. 146 ). The parties shall file opening claim construction briefs on January 12, 2023, and rebuttal claim construction briefs on March 1, 2023. Signed by Chief District Judge Thomas S Kleeh on 12/12/2022. (dk) (Entered: 12/12/2022) (1) |
| Dec 9, 2022 | 146 | Joint MOTION for Extension of Time to File Claim Construction Deadlines Without Other Impact On Case Schedule by Mylan Pharmaceuticals Inc.. (O'Brien, William) (Entered: 12/09/2022) (3) |
| Nov 30, 2022 | 145 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. Defendants Responses and Objections to Plaintiffs Second Set of Requests for the Production of Documents and Things. (Copland, Gordon) (Entered: 11/30/2022) (2) |
| Nov 29, 2022 | 143 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of documents bates numbers TRUL00769540 - TRUL01153301, TRUL01154340 - TRUL01173779 and certain metadata and extracted text provided in response to discovery requests of Defendant. (Higginbotham, Daniel) (Entered: 11/29/2022) (2) |
| Nov 29, 2022 | 144 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Objections and Responses to Defendant Mylan Pharmaceuticals Inc.'s Second Set of Interrogatories (No. 3). (Higginbotham, Daniel) (Entered: 11/29/2022) (2) |
| Nov 22, 2022 | 141 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Initial Disclosure Statement. (Higginbotham, Daniel) (Entered: 11/22/2022) (2) |
| Nov 22, 2022 | 142 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Documents produced on 11.22.22). (O'Brien, William) (Entered: 11/22/2022) (1) |
| Nov 21, 2022 | 138 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Third Set of Interrogatories to Plaintiffs (No. 4)). (O'Brien, William) (Entered: 11/21/2022) (1) |
| Nov 21, 2022 | 139 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Second Preliminary Non-Infringement Contentions). (O'Brien, William) (Entered: 11/21/2022) (1) |
| Nov 21, 2022 | 140 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Invalidity Contentions Regarding U.S. Patent Nos. 11,142,549 and 11,319,346). (O'Brien, William) (Entered: 11/21/2022) (1) |
| Nov 10, 2022 | 137 | ORDER. Signed by Chief District Judge Thomas S Kleeh on 11/10/2022. (dk) (Entered: 11/10/2022) (2) |
| Nov 8, 2022 | 136 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Supplemental Infringement Contentions. (Higginbotham, Daniel) (Entered: 11/08/2022) (2) |
| Oct 31, 2022 | 135 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Second Set of Requests to Defendant for the Production of Documents and Things. (Higginbotham, Daniel) (Entered: 10/31/2022) (2) |
| Oct 28, 2022 | 132 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Second Set of Interrogatories to Plaintiffs (No. 3)). (O'Brien, William) (Entered: 10/28/2022) (1) |
| Oct 28, 2022 | 133 | NOTICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc of Filing Joint Motion to Consolidate (Attachments: # 1 Exhibit 1)(Higginbotham, Daniel) (Entered: 10/28/2022) (Main Document) (2) |
| Oct 28, 2022 | 134 | Joint Claim Construction Statement Other Document filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Exhibit Intrinsic and Extrinsic Evidence Chart)(Higginbotham, Daniel) (Entered: 10/28/2022) (Main Document) (6) |
| Oct 28, 2022 | 133 | NOTICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc of Filing Joint Motion to Consolidate (Attachments: # 1 Exhibit 1)(Higginbotham, Daniel) (Entered: 10/28/2022) (Exhibit 1) (6) |
| Oct 28, 2022 | 134 | Joint Claim Construction Statement Other Document filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # 1 Exhibit Intrinsic and Extrinsic Evidence Chart)(Higginbotham, Daniel) (Entered: 10/28/2022) (Exhibit Intrinsic and Extrinsic Evidence Chart) (30) |
| Oct 21, 2022 | 131 | ORDER GRANTING 130 MOTION TO WITHDRAW. The Court GRANTS the motion and DIRECTS the Clerk to terminate Attorney Aden M. Allen from the list of attorneys in this case. Signed by Chief District Judge Thomas S Kleeh on 10/21/2022. (dk) (Entered: 10/21/2022) (1) |
| Oct 17, 2022 | 129 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. MPIs Rebuttal Claim Construction Positions and Objections. (Copland, Gordon) (Entered: 10/17/2022) (2) |
| Oct 17, 2022 | 130 | MOTION to Withdraw as Attorney - Aden M. Allen by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(Copland, Gordon) (Entered: 10/17/2022) (Main Document) (2) |
| Oct 17, 2022 | 130 | MOTION to Withdraw as Attorney - Aden M. Allen by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(Copland, Gordon) (Entered: 10/17/2022) (Proposed Order) (1) |
| Oct 14, 2022 | 128 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc re 122 Certificate of Service certifying service of Plaintiffs' Objections and Responses to Defendant's First Set of Interrogatories (Nos. 1-2) to Plaintiffs. (Higginbotham, Daniel) (Entered: 10/14/2022) (2) |
| Oct 13, 2022 | 127 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Identification of Intrinsic and Extrinsic Evidence to Oppose Defendant's Proposed Claim Constructions. (Higginbotham, Daniel) (Entered: 10/13/2022) (2) |
| Oct 12, 2022 | 125 | ORDER GRANTING DEFENDANT'S MOTION FOR LEAVE TO FILE UNDER SEAL. The Court, finding good cause, GRANTS the motion [ECF No. 119] and DIRECTS the Clerk of Court to file Notice of Service of Invalidity and Non-Infringement Contentions [ECF No. 119-1] and Exhibits A, B, C and D to the Notice [ECF Nos. 119-2, 119-3, 119-4, 119-5] UNDER SEAL. Signed by Chief District Judge Thomas S Kleeh on 10/12/2022. (dk) (Entered: 10/12/2022) (2) |
| Sep 29, 2022 | 123 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Preliminary Proposed Claim Constructions and Identification of Evidence. (Higginbotham, Daniel) (Entered: 09/29/2022) (2) |
| Sep 29, 2022 | 124 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (Preliminary Claim Construction and Identification of Evidence). (O'Brien, William) (Entered: 09/29/2022) (2) |
| Sep 26, 2022 | 122 | CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. (First Set of Interrogatories to Plaintiffs (Nos. 1-2)). (O'Brien, William) (Entered: 09/26/2022) (2) |
| Sep 21, 2022 | 120 | STIPULATION Continuing Deadlines in the Scheduling Order by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) (Entered: 09/21/2022) (2) |
| Sep 21, 2022 | 121 | ORDER ADOPTING JOINT STIPULATION. Signed by Chief District Judge Thomas S Kleeh on 9/21/2022. (dk) (Entered: 09/21/2022) (2) |
| Sep 15, 2022 | 118 | CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' First Set of Interrogatories to Defendant. (Higginbotham, Daniel) (Entered: 09/15/2022) (2) |
| Aug 5, 2022 | 117 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Disclosure of Asserted Claims and Infringement Contentions. (Higginbotham, Daniel) |
| Aug 4, 2022 | 116 | Protective Order (28) Docket Text:STIPULATED PROTECTIVE ORDER. Signed by Chief District Judge Thomas S Kleeh on 8/4/22. (jss) |
| Aug 3, 2022 | 115 | Proposed Order -- NOT PRETRIAL (30) Docket Text: Proposed Stipulated Protective Order by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) |
| Jul 13, 2022 | 113 | Reply to Response to Motion (14) Docket Text: REPLY to Response to Motion re [103] MOTION for Judgment on the Pleadings MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTION to Strike [99] Answer to Amended Complaint, Counterclaim filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) |
| Jul 13, 2022 | 114 | Other Document (30) Docket Text:Plaintiff's Answer to Defendant's First Amended Counterclaims Other Document re [110] Amended Document filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) |
| Jun 30, 2022 | 112 | Scheduling Order (8) Docket Text:SCHEDULING ORDER: Markman Hearing set for 3/22/2023 11:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S Kleeh. Discovery due by 3/23/2023. Motions due by 1/31/2024. Proposed Pretrial Order due by 5/1/2024. Final Pretrial Conference/Settlement Conference set for 5/29/2024 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S Kleeh. Bench Trial set for 6/17/2024 09:30 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S Kleeh. Signed by Chief District Judge Thomas S Kleeh on 6/30/2022. (dk) |
| Jun 29, 2022 | 110 | Amended Document (30) Docket Text: AMENDED DOCUMENT by Mylan Pharmaceuticals Inc.. DEFENDANT MYLAN PHARMACEUTICALS INC.S ANSWER, DEFENSES, AND FIRST AMENDED COUNTERCLAIMS TO PLAINTIFFS AMENDED COMPLAINT. (Copland, Gordon) |
| Jun 29, 2022 | 111 | Response in Opposition to Motion (22) Docket Text: RESPONSE in Opposition re [103] MOTION for Judgment on the Pleadings MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTION to Strike [99] Answer to Amended Complaint, Counterclaim "Defendants Opposition to Plaintiffs Rule 12 Motions" filed by Mylan Pharmaceuticals Inc.. (Copland, Gordon) |
| Jun 28, 2022 | 109 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Bausch Health Ireland Limited certifying service of Plaintiffs' Objections and Responses to Defendant's First Set of Requests for Production of Documents and Things (Nos. 1-132) to Plaintiffs. (Higginbotham, Daniel) |
| Jun 27, 2022 | 108 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Mylan Pharmaceuticals Inc. for Defendant's Responses and Objections to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-120). (Copland, Gordon) |
| Jun 22, 2022 | 107 | Order (1) Docket Text:STIPULATION TO EXTENSION OF TIME re [103]. Signed by Chief District Judge Thomas S Kleeh on 6/22/2022. (dk) |
| Jun 17, 2022 | 106 | Stipulation (4) Docket Text: STIPULATION re [103] MOTION for Judgment on the Pleadings MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTION to Strike [99] Answer to Amended Complaint, Counterclaim to Extension of Time by Bausch Health Ireland Limited. (Higginbotham, Daniel) |
| Jun 8, 2022 | 103 | Motion for Judgment on the Pleadings (3) Docket Text: MOTION for Judgment on the Pleadings ( Responses due by 6/22/2022), MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM , MOTION to Strike [99] Answer to Amended Complaint, Counterclaim by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) |
| Jun 8, 2022 | 104 | Main Document (15) Docket Text: Memorandum in Support re [103] MOTION for Judgment on the Pleadings MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTION to Strike [99] Answer to Amended Complaint, Counterclaim filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A)(Higginbotham, Daniel) |
| Jun 8, 2022 | 104 | Exhibit A (98) |
| Jun 8, 2022 | 105 | Other Document (30) Docket Text:Plaintiffs' Answer to Defendant's Counterclaims Other Document re [99] Answer to Amended Complaint, Counterclaim filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) |
| May 26, 2022 | 102 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Initial Disclosure Statement. (Higginbotham, Daniel) |
| May 24, 2022 | 101 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' Asserted Claims Letter. (Higginbotham, Daniel) |
| May 23, 2022 | 100 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc certifying service of Plaintiffs' First Set of Requests to Defendant for the Production of Documents and Things. (Higginbotham, Daniel) |
| May 19, 2022 | 99 | Answer to Amended Complaint (30) Docket Text: ANSWER to [91] Amended Complaint, and defenses and, COUNTERCLAIM against all Defendants against Mylan Pharmaceuticals Inc. by Mylan Pharmaceuticals Inc..(Copland, Gordon) |
| May 16, 2022 | 98 | Main Document (38) Docket Text: REPORT of Rule 26(f) Planning Meeting. (Attachments: # (1) Exhibit Checklist, # (2) Exhibit Astellas Report, # (3) Exhibit Astellas Order)(Higginbotham, Daniel) |
| May 16, 2022 | 98 | Exhibit Checklist (3) |
| May 16, 2022 | 98 | Exhibit Astellas Report (9) |
| May 16, 2022 | 98 | Exhibit Astellas Order (8) |
| May 11, 2022 | 97 | Order on Motion to Withdraw as Attorney (1) Docket Text:ORDER GRANTING MOTION TO WITHDRAW (ECF. NO. [94]). For good cause, the Court GRANTS the motion and DIRECTS the Clerk to terminate Attorneys Arnold B. Calmann, Catherine Magdy Soliman and Jakob Benjamin Halpern from the list of attorneys in this case. Signed by Chief District Judge Thomas S Kleeh on 5/11/2022. (dk) |
| May 10, 2022 | 95 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [87] Motion of Dennis Gregory for Leave to Appear Pro Hac Vice on behalf of Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 5/10/2022. (dk) |
| May 10, 2022 | 96 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [86] Motion of Nicole Stafford for Leave to Appear Pro Hac Vice on behalf of Mylan Pharmaceuticals Inc. Signed by Chief District Judge Thomas S Kleeh on 5/10/2022. (dk) |
| May 9, 2022 | 92 | Main Document (3) Docket Text: Joint MOTION Extend the Time for Submission of the Parties' Planning Report by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Copland, Gordon) |
| May 9, 2022 | 92 | Proposed Order (1) |
| May 9, 2022 | 93 | Order on Motion for Miscellaneous Relief (1) Docket Text:ORDER. For good cause shown, the [92] motion is GRANTED and it is ORDERED that the Parties shall meet and confer on existing areas of disagreement on or before May 11, 2022, and that the parties have through and until May 16, 2022, to file their initial Planning Report. Signed by Chief District Judge Thomas S Kleeh on 5/9/2022. (dk) |
| May 9, 2022 | 94 | Main Document (3) Docket Text: MOTION to Withdraw as Attorney -Arnold B. Calmann, Catherine Magdy Soliman and Jakob Benjamin Halpern by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Copland, Gordon) |
| May 9, 2022 | 94 | Proposed Order (1) |
| May 5, 2022 | 88 | Main Document (5) Docket Text: STIPULATION TO FILE AMENDED COMPLAINT AND AMEND CASE CAPTION by Bausch Health Ireland Limited. (Attachments: # (1) Exhibit A to Stipulation (Amended Complaint), # (2) Exhibit A to Amended Complaint, # (3) Exhibit B to Amended Complaint, # (4) Exhibit C to Amended Complaint, # (5) Exhibit D to Amended Complaint, # (6) Exhibit E to Amended Complaint, # (7) Exhibit F to Amended Complaint)(Higginbotham, Daniel) |
| May 5, 2022 | 88 | Exhibit A to Stipulation (Amended Complaint) (13) |
| May 5, 2022 | 88 | Exhibit A to Amended Complaint (23) |
| May 5, 2022 | 88 | Exhibit B to Amended Complaint (139) |
| May 5, 2022 | 88 | Exhibit C to Amended Complaint (133) |
| May 5, 2022 | 88 | Exhibit D to Amended Complaint (127) |
| May 5, 2022 | 88 | Exhibit E to Amended Complaint (137) |
| May 5, 2022 | 88 | Exhibit F to Amended Complaint (124) |
| May 5, 2022 | 90 | Order on Motion to Strike (4) Docket Text:STIPULATION TO FILE AMENDED COMPLAINT AND AMEND CASE CAPTION. The proposed First Amended Complaint will be entered on the docket. Mylan Pharmaceuticals, Inc.'s [83] MOTION is dismissed as moot. Defendants Mylan Inc., Mylan Laboratories Ltd., Viatris Inc., Agila Specialties Inc. and Mylan API US LLC terminated. Signed by Chief District Judge Thomas S Kleeh on 5/5/2022. (dk) |
| May 5, 2022 | 91 | Main Document (12) Docket Text: FIRST AMENDED COMPLAINT against Mylan Pharmaceuticals Inc., filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(dk) |
| May 5, 2022 | 91 | Exhibit A (23) |
| May 5, 2022 | 91 | Exhibit B (139) |
| May 5, 2022 | 91 | Exhibit C (133) |
| May 5, 2022 | 91 | Exhibit D (127) |
| May 5, 2022 | 91 | Exhibit E (137) |
| May 5, 2022 | 91 | Exhibit F (124) |
| May 5, 2022 | 91 | Amended Complaint* (1) |
| May 3, 2022 | 86 | Motion for Leave to Appear (3) Docket Text: MOTION for Leave to Appear pro hac vice for Nicole Stafford by Mylan Pharmaceuticals Inc.. (Copland, Gordon) |
| May 3, 2022 | 87 | Main Document (3) Docket Text: MOTION for Leave to Appear pro hac vice Dennis Gregory by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Copland, Gordon) |
| May 3, 2022 | 87 | Proposed Order (1) |
| Apr 29, 2022 | 84 | Stipulation (2) Docket Text: STIPULATION to Extension of Time by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Higginbotham, Daniel) |
| Apr 29, 2022 | 85 | Stipulation and Order (2) Docket Text:ORDER ADOPTING STIPULATION TO EXTEND TIME: The parties to this matter STIPULATE and AGREE that the date by which Plaintiffs shall respond to Defendant's [83] MOTION to Strike is EXTENDED through and until 5/10/2022. Signed by Chief District Judge Thomas S Kleeh on 1/29/2022. (cnd) |
| Apr 19, 2022 | 83 | Main Document (9) Docket Text: MOTION to Strike Defendant Mylan Pharmaceuticals Inc.s Motion, Pursuant To Fed. R. Civ. P. 12(F), to Strike Portions of Plaintiffs Complaint by Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit Ex 1 - NJ Opinion, # (2) Exhibit Ex 2 - NJ Order, # (3) Exhibit Ex 3 - Kim Email 4/12/22, # (4) Exhibit Ex 4 - Ward Email 4/18/22, # (5) Exhibit Ex 5 Kim Email 4/18/22, # (6) Exhibit Ex 6 - Ward Email 4/19/22, # (7) Exhibit Ex 7 - Complaint, Hightlighted, # (8) Proposed Order)(Copland, Gordon) |
| Apr 19, 2022 | 83 | Exhibit Ex 1 - NJ Opinion (26) |
| Apr 19, 2022 | 83 | Exhibit Ex 2 - NJ Order (3) |
| Apr 19, 2022 | 83 | Exhibit Ex 3 - Kim Email 4/12/22 (8) |
| Apr 19, 2022 | 83 | Exhibit Ex 4 - Ward Email 4/18/22 (8) |
| Apr 19, 2022 | 83 | Exhibit Ex 5 Kim Email 4/18/22 (9) |
| Apr 19, 2022 | 83 | Exhibit Ex 6 - Ward Email 4/19/22 (14) |
| Apr 19, 2022 | 83 | Exhibit Ex 7 - Complaint, Hightlighted (44) |
| Apr 19, 2022 | 83 | Proposed Order (2) |
| Apr 12, 2022 | N/A | Set/Reset Deadlines (0) Docket Text: Set/Reset Deadlines: Reset Answer deadline for All Defendants. (jss) |
| Apr 12, 2022 | 81 | Stipulation (2) Docket Text: STIPULATION STIPULATION TO EXTEND ANSWER DATE by Mylan API US LLC, Mylan Inc., Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc., Viatris Inc.. (Copland, Gordon) |
| Apr 12, 2022 | 82 | Order (2) Docket Text:ORDER ADOPTING JOINT STIPULATION. Signed by Chief District Judge Thomas S Kleeh on 4/12/22. (jss) |
| Apr 6, 2022 | 80 | Order on Motion to Withdraw as Attorney (2) Docket Text:ORDER GRANTING [79] MOTION FOR LEAVE TO WITHDRAW AS COUNSEL. The Court GRANTS the motion to withdraw and DIRECTS the Clerk to terminate Ms. Deem as counsel of record and to remove them from the Courts case management/electronic case files ("CM/ECF") notifications for this case. Signed by Chief District Judge Thomas S Kleeh on 4/6/2022. (dk) |
| Apr 5, 2022 | 79 | Main Document (3) Docket Text: MOTION to Withdraw as Attorney of Ashley N. Deem by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| Apr 5, 2022 | 79 | Proposed Order (2) |
| Apr 1, 2022 | 78 | Order on Motion to Withdraw as Attorney (1) Docket Text:ORDER GRANTING [77] MOTION FOR LEAVE TO WITHDRAW AS COUNSEL. The Court GRANTS the motion to withdraw and DIRECTS the Clerk to terminate Mr. Lower, Mr. Etish and Mr. Deni as counsel of record and to remove them from the Court's case management/electronic case files (CM/ECF) notifications for this case. Signed by Chief District Judge Thomas S Kleeh on 4/1/2022. (dk) |
| Mar 25, 2022 | 77 | Main Document (3) Docket Text: MOTION to Withdraw as Attorney by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| Mar 25, 2022 | 77 | Proposed Order (2) |
| Mar 23, 2022 | 76 | FirstOrder (6) Docket Text:FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING CONFERENCE ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 4/25/2022. Rule 26 Meeting Report due by 5/9/2022. Discovery due by 5/25/2022. Signed by Chief Judge Thomas S. Kleeh on 03/23/2022. (kam) |
| Mar 22, 2022 | 68 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Charles E. Lipsey by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| Mar 22, 2022 | 68 | Proposed Order (1) |
| Mar 22, 2022 | 69 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [65] Motion for Leave to Appear Pro Hac Vice of Caitlin E. O'Connell. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
| Mar 22, 2022 | 70 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [62] Motion for Leave to Appear Pro Hac Vice of Bryan C. Diner. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
| Mar 22, 2022 | 71 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [64] Motion for Leave to Appear Pro Hac Vice of Kyu Yun Kim. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
| Mar 22, 2022 | 72 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [63] Motion for Leave to Appear Pro Hac Vice of Justin J. Hasford. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
| Mar 22, 2022 | 74 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [68] Motion for Leave to Appear Pro Hac Vice of Charles E. Lipsey. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
| Mar 22, 2022 | 75 | Stipulation and Order (2) Docket Text:ORDER ADOPTING JOINT STIPULATION. The Court ADOPTS the [67] joint stipulation, Defendants shall have until and including April 12, 2022, to file a responsive pleading to the Complaint. Signed by Chief Judge Thomas S. Kleeh on 03/22/2022. (kam) |
| Mar 21, 2022 | 67 | Stipulation (2) Docket Text: STIPULATION of the parties extending answer or responsive pleading date by Agila Specialties Inc., Mylan API US LLC, Mylan Inc., Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc., Viatris Inc.. (Copland, Gordon) |
| Mar 18, 2022 | 62 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Bryan C. Diner by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| Mar 18, 2022 | 62 | Proposed Order (1) |
| Mar 18, 2022 | 63 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Justin J. Hasford by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| Mar 18, 2022 | 63 | Proposed Order (1) |
| Mar 18, 2022 | 64 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Kyu Yun Kim by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| Mar 18, 2022 | 64 | Proposed Order (1) |
| Mar 18, 2022 | 65 | Main Document (5) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Caitlin E. O'Connell by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (Attachments: # (1) Proposed Order)(Higginbotham, Daniel) |
| Mar 18, 2022 | 65 | Proposed Order (1) |
| Mar 17, 2022 | 60 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Daniel R. Higginbotham on behalf of Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc (Higginbotham, Daniel) |
| Mar 17, 2022 | 61 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Ashley Nichole Deem on behalf of Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc (Deem, Ashley) |
| Mar 10, 2022 | 59 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Gordon H. Copland on behalf of All Defendants (Copland, Gordon) |
| Mar 9, 2022 | 57 | Main Document Public Docket Sheet (10) Docket Text: Case transferred in from District of New Jersey; Case Number 2:21-cv-10403. (kam) |
| Mar 9, 2022 | 57 | *Restricted* (10) |
| Mar 9, 2022 | 58 | Notice of Verification of Attorney Admission (1) Docket Text: VERIFICATION OF ATTORNEY ADMISSION re: Bryan C. Diner, Esq., J. Brugh Lower, Esq., Justin James Hansford, Esq., Scott Joel Etish, Esq., William P. Deni, Jr., Arnold B. Calmann, Esq., Catherine Magdy Soliman, Esq., Jakob Benjamin Halpern, Esq. Sent via NEF ECF. (kam) |
| Mar 8, 2022 | N/A | Terminated Case (0) Docket Text: ***Civil Case Terminated. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Mar 8, 2022 | 55 | Memorandum & Opinion (25) Docket Text: OPINION. Signed by Judge Stanley R. Chesler on 3/8/2022. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Mar 8, 2022 | 56 | Order on Motion to Dismiss (2) Docket Text: ORDER that Defendants' [26] Motion to Dismiss is GRANTED in part and DENIED in part; Plaintiff's [34] Cross-Motion will be DENIED; The action and all remaining claims will be TRANSFERRED to the Northern District of West Virginia. etc. Signed by Judge Stanley R. Chesler on 3/8/2022. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Mar 4, 2022 | 54 | Main Document (2) Docket Text: Letter from William P. Deni, Jr. to the Honorable Stanley R. Chesler, U.S.D.J. re [26] MOTION to Dismiss , [34] Cross MOTION for Discovery . (Attachments: # (1) Exhibit 1)(DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Mar 4, 2022 | 54 | Exhibit 1 (26) |
| Jan 28, 2022 | 53 | Order on Motion to Seal (7) Docket Text: ORDER granting [52] Motion to Seal. etc. Signed by Magistrate Judge Jessica S. Allen on 1/28/2022. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Jan 14, 2022 | N/A | Set Motion, Evidentiary, R&R and Social Security Oral Arguments Deadlines/Hearings (0) Docket Text: Set Deadlines as to [52] MOTION to Seal . Motion set for 2/7/2022 before Judge Stanley R. Chesler. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Jan 13, 2022 | 49 | Main Document (116) Docket Text: REDACTION to [27] Declaration,, of Keith Meckstroth in support of Defendants' Motion to Dismiss by AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC.. (Attachments: # (1) Brief in support of Defendants' Motion to Dismiss)(HALPERN, JAKOB) [Transferred from New Jersey on 3/9/2022.] |
| Jan 13, 2022 | 49 | Brief in support of Defendants' Motion to Dismiss (38) |
| Jan 13, 2022 | 50 | Main Document (43) Docket Text: REDACTION to [35] Brief in Opposition to Motion,,,,,, by AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC.. (Attachments: # (1) Declaration of William P. Deni, Jr.,, # (2) Exhibit 1 (unredacted version), # (3) Exhibit 2 (unredacted version), # (4) Exhibit 3 (unredacted version), # (5) Exhibit 4 (unredacted version), # (6) Exhibit 5 (unredacted version), # (7) Exhibit 6 (unredacted version), # (8) Exhibit 7 (unredacted version), # (9) Exhibit 8 (unredacted version), # (10) Exhibit 9 (unredacted version), # (11) Exhibit 10 (unredacted version), # (12) Exhibit 11 (unredacted version), # (13) Exhibit 12 (unredacted version), # (14) Exhibit 13 (unredacted version), # (15) Exhibit 14 (unredacted version), # (16) Exhibit 15 (unredacted version), # (17) Exhibit 16 (unredacted version), # (18) Exhibit 17 (unredacted version), # (19) Exhibit 18 (unredacted version), # (20) Exhibit 19 (unredacted version), # (21) Exhibit 20 (unredacted version), # (22) Exhibit 21 (unredacted version), # (23) Exhibit 22 (redacted version), # (24) Exhibit 23 (unredacted version), # (25) Exhibit 24 (redacted version), # (26) Exhibit 25 (redacted version), # (27) Exhibit 26 (redacted version), # (28) Exhibit 27 (redacted version), # (29) Exhibit 28 (unredacted version), # (30) Exhibit 29 (redacted version), # (31) Exhibit 30 (unredacted version), # (32) Exhibit 31 (redacted version), # (33) Exhibit 32 (unredacted version), # (34) Exhibit 33 (unredacted version), # (35) Exhibit 34 (unredacted version), # (36) Exhibit 35 (unredacted version), # (37) Exhibit 36 (unredacted version), # (38) Exhibit 37 (unredacted version), # (39) Exhibit 38 (unredacted version), # (40) Exhibit 39 (unredacted version), # (41) Exhibit 40 (unredacted version), # (42) Exhibit 41 (unredacted version), # (43) Exhibit 42 (unredacted version), # (44) Exhibit 43 (unredacted version), # (45) Exhibit 44 (unredacted version), # (46) Exhibit 45 (unredacted version), # (47) Exhibit 46 (unredacted version), # (48) Exhibit 47 (unredacted version), # (49) Exhibit 48 (unredacted version), # (50) Exhibit 49 (unredacted version), # (51) Exhibit 50 (unredacted version), # (52) Exhibit 51 (redacted version), # (53) Exhibit 52 (redacted version), # (54) Exhibit 53 (redacted version), # (55) Certificate of Service)(HALPERN, JAKOB) [Transferred from New Jersey on 3/9/2022.] |
| Jan 13, 2022 | 50 | Declaration of William P. Deni, Jr., (8) |
| Jan 13, 2022 | 50 | Exhibit 1 (unredacted version) (23) |
| Jan 13, 2022 | 50 | Exhibit 2 (unredacted version) (98) |
| Jan 13, 2022 | 50 | Exhibit 3 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 4 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 5 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 6 (unredacted version) (4) |
| Jan 13, 2022 | 50 | Exhibit 7 (unredacted version) (4) |
| Jan 13, 2022 | 50 | Exhibit 8 (unredacted version) (4) |
| Jan 13, 2022 | 50 | Exhibit 9 (unredacted version) (3) |
| Jan 13, 2022 | 50 | Exhibit 10 (unredacted version) (3) |
| Jan 13, 2022 | 50 | Exhibit 11 (unredacted version) (3) |
| Jan 13, 2022 | 50 | Exhibit 12 (unredacted version) (3) |
| Jan 13, 2022 | 50 | Exhibit 13 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 14 (unredacted version) (9) |
| Jan 13, 2022 | 50 | Exhibit 15 (unredacted version) (20) |
| Jan 13, 2022 | 50 | Exhibit 16 (unredacted version) (3) |
| Jan 13, 2022 | 50 | Exhibit 17 (unredacted version) (6) |
| Jan 13, 2022 | 50 | Exhibit 18 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 19 (unredacted version) (9) |
| Jan 13, 2022 | 50 | Exhibit 20 (unredacted version) (6) |
| Jan 13, 2022 | 50 | Exhibit 21 (unredacted version) (5) |
| Jan 13, 2022 | 50 | Exhibit 22 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 23 (unredacted version) (3) |
| Jan 13, 2022 | 50 | Exhibit 24 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 25 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 26 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 27 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 28 (unredacted version) (7) |
| Jan 13, 2022 | 50 | Exhibit 29 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 30 (unredacted version) (29) |
| Jan 13, 2022 | 50 | Exhibit 31 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 32 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 33 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 34 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 35 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 36 (unredacted version) (2) |
| Jan 13, 2022 | 50 | Exhibit 37 (unredacted version) (7) |
| Jan 13, 2022 | 50 | Exhibit 38 (unredacted version) (17) |
| Jan 13, 2022 | 50 | Exhibit 39 (unredacted version) (4) |
| Jan 13, 2022 | 50 | Exhibit 40 (unredacted version) (5) |
| Jan 13, 2022 | 50 | Exhibit 41 (unredacted version) (16) |
| Jan 13, 2022 | 50 | Exhibit 42 (unredacted version) (48) |
| Jan 13, 2022 | 50 | Exhibit 43 (unredacted version) (13) |
| Jan 13, 2022 | 50 | Exhibit 44 (unredacted version) (9) |
| Jan 13, 2022 | 50 | Exhibit 45 (unredacted version) (6) |
| Jan 13, 2022 | 50 | Exhibit 46 (unredacted version) (3) |
| Jan 13, 2022 | 50 | Exhibit 47 (unredacted version) (12) |
| Jan 13, 2022 | 50 | Exhibit 48 (unredacted version) (13) |
| Jan 13, 2022 | 50 | Exhibit 49 (unredacted version) (5) |
| Jan 13, 2022 | 50 | Exhibit 50 (unredacted version) (6) |
| Jan 13, 2022 | 50 | Exhibit 51 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 52 (redacted version) (1) |
| Jan 13, 2022 | 50 | Exhibit 53 (redacted version) (1) |
| Jan 13, 2022 | 50 | Certificate of Service (2) |
| Jan 13, 2022 | 51 | Main Document (33) Docket Text: REDACTION to [39] Reply Brief to Opposition to Motion,,, by AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC.. (Attachments: # (1) Declaration of Dr. Ravishanker Kovi in support of Defendants' Motion to Dismiss, # (2) Declaration of Jennifer Ward in support of Defendants' Motion to Dismiss, # (3) Declaration (Supplemental Declaration) of Keith Meckstroth in support of Defendants' Motion to Dismiss, # (4) Certificate of Service)(HALPERN, JAKOB) [Transferred from New Jersey on 3/9/2022.] |
| Jan 13, 2022 | 51 | Declaration of Dr. Ravishanker Kovi in support of Defendants' Motion to Dis (13) |
| Jan 13, 2022 | 51 | Declaration of Jennifer Ward in support of Defendants' Motion to Dismiss (38) |
| Jan 13, 2022 | 51 | Declaration (Supplemental Declaration) of Keith Meckstroth in support of Defenda (3) |
| Jan 13, 2022 | 51 | Certificate of Service (2) |
| Jan 13, 2022 | 52 | Main Document (3) Docket Text: MOTION to Seal by AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC.. (Attachments: # (1) Declaration of Matthew Greinert in support of motion to seal, # (2) Index (Exhibit 1 to the Declaration of Matthew Greinert), # (3) Declaration of Dr. Ravishanker Kovi in support of motion to seal, # (4) Index (Exhibit 1 to the Declaration of Dr. Ravishanker Kovi), # (5) Text of Proposed Order, # (6) Certificate of Service)(HALPERN, JAKOB) [Transferred from New Jersey on 3/9/2022.] |
| Jan 13, 2022 | 52 | *Restricted* (3) |
| Jan 13, 2022 | 52 | *Restricted* (3) |
| Jan 13, 2022 | 52 | *Restricted* (3) |
| Jan 13, 2022 | 52 | *Restricted* (3) |
| Jan 13, 2022 | 52 | *Restricted* (3) |
| Jan 13, 2022 | 52 | *Restricted* (3) |
| Jan 5, 2022 | 48 | Order (2) Docket Text: ORDER granting [47] Letter requesting that the deadline to file both the motion to seal and redacted copies be adjourned to 1/13/2022. Signed by Magistrate Judge Jessica S. Allen on 1/5/2022. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Jan 4, 2022 | 47 | Letter (2) Docket Text: Letter from defendants Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC, Mylan Inc., Viatris Inc., and Mylan Pharmaceuticals Inc. to Magistrate Judge Allen. (HALPERN, JAKOB) [Transferred from New Jersey on 3/9/2022.] |
| Jan 3, 2022 | 46 | Order (3) Docket Text: ORDER re [44] Letter; Plaintiffs' request for oral argument or leave to file a sur reply is DENIED. etc. Signed by Judge Stanley R. Chesler on 1/3/2022. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Dec 23, 2021 | 45 | Letter (2) Docket Text: Letter from defendants Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC, Mylan Inc., Viatris Inc., and Mylan Pharmaceuticals Inc. to District Judge Chesler re [44] Letter,. (HALPERN, JAKOB) [Transferred from New Jersey on 3/9/2022.] |
| Dec 22, 2021 | 44 | Main Document (3) Docket Text: Letter from William P. Deni, Jr. to the Honorable Stanley R. Chesler, U.S.D.J. re: request for oral argument and/or leave to file sur reply re [26] MOTION to Dismiss , [34] Cross MOTION for Discovery . (Attachments: # (1) Exhibit 1)(DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Dec 22, 2021 | 44 | Exhibit 1 (13) |
| Dec 16, 2021 | N/A | Notice (Other) (0) Docket Text: Pro Hac Vice counsel, CHARLES E. LIPSEY, CAITLIN E. O'CONNELL and KYU YUN KIM, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Dec 15, 2021 | 41 | Notice (Other) (1) Docket Text: Notice of Request by Pro Hac Vice Charles E. Lipsey, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13043571.) (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Dec 15, 2021 | 42 | Notice (Other) (1) Docket Text: Notice of Request by Pro Hac Vice Caitlin E. OConnell, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13043587.) (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Dec 15, 2021 | 43 | Notice (Other) (1) Docket Text: Notice of Request by Pro Hac Vice Kyu Yun Kim, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13043602.) (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Dec 13, 2021 | 40 | Order (2) Docket Text: ORDER granting [38] Application for the Pro Hac Vice Admission of Charles E. Lipsey, Caitlin E. O'Connell and Kyu Yun Kim. etc. Signed by Magistrate Judge Jessica S. Allen on 12/13/2021. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Dec 10, 2021 | 38 | Main Document (1) Docket Text: Letter from William P. Deni, Jr. to the Honorable Jessica S. Allen, U.S.M.J. re: application for pro hac vice admissions of Charles E. Lipsey, Caitlin E. O'Connell, and Kyu Yun Kim. (Attachments: # (1) Certification of William P. Deni, Jr., # (2) Certification of Charles E. Lipsey, # (3) Certification of Caitlin E. O'Connell, # (4) Certification of Kyu Yun Kim, # (5) Text of Proposed Order)(DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Dec 10, 2021 | 38 | Certification of William P. Deni, Jr. (2) |
| Dec 10, 2021 | 38 | Certification of Charles E. Lipsey (3) |
| Dec 10, 2021 | 38 | Certification of Caitlin E. O'Connell (3) |
| Dec 10, 2021 | 38 | Certification of Kyu Yun Kim (3) |
| Dec 10, 2021 | 38 | Text of Proposed Order (2) |
| Dec 6, 2021 | N/A | Set Motion, Evidentiary, R&R and Social Security Oral Arguments Deadlines/Hearings (0) Docket Text: Reset Deadlines as to [26] MOTION to Dismiss . Motion set for 12/20/2021 before Judge Stanley R. Chesler. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Dec 6, 2021 | 37 | Order (2) Docket Text: ORDER granting [36] Letter requesting an extension of time until 12/13/2021 to file reply brief. Signed by Judge Stanley R. Chesler on 12/6/2021. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Dec 3, 2021 | 36 | Letter (2) Docket Text: Letter from defendants Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC, Mylan Inc., Viatris Inc., and Mylan Pharmaceuticals Inc. to District Judge Chesler. (HALPERN, JAKOB) [Transferred from New Jersey on 3/9/2022.] |
| Nov 16, 2021 | N/A | Set Motion, Evidentiary, R&R and Social Security Oral Arguments Deadlines/Hearings (0) Docket Text: Set Deadlines as to [34] Cross MOTION for Discovery . Motion set for 12/20/2021 before Judge Stanley R. Chesler. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Nov 15, 2021 | 34 | Main Document (2) Docket Text: Cross MOTION for Discovery by BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC.. (Attachments: # (1) Text of Proposed Order, # (2) Certificate of Service)(DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Nov 15, 2021 | 34 | Text of Proposed Order (1) |
| Nov 15, 2021 | 34 | Certificate of Service (2) |
| Nov 12, 2021 | 33 | Letter (1) Docket Text: Letter from William P. Deni, Jr. to the Honorable Stanley R. Chesler, U.S.D.J. re: request for extension of page limit. (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Nov 8, 2021 | 32 | Letter (30) Docket Text: Letter from defendants Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC, Mylan Inc., Viatris Inc., and Mylan Pharmaceuticals Inc. to District Judge Chesler re [26] MOTION to Dismiss . (HALPERN, JAKOB)[Transferred from New Jersey on 3/9/2022.] |
| Oct 27, 2021 | 31 | Order (1) Docket Text: ORDER granting [30] Letter re Briefing Schedule for [26] Motion to Dismiss. Signed by Judge Stanley R. Chesler on 10/27/2021. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Oct 26, 2021 | 30 | Letter (1) Docket Text: Letter from William P. Deni, Jr. to the Honorable Stanley R. Chesler, U.S.D.J. re: extension request. (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Oct 18, 2021 | 29 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by SCOTT JOEL ETISH on behalf of BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. (ETISH, SCOTT) [Transferred from New Jersey on 3/9/2022.] |
| Oct 13, 2021 | 28 | Letter (1) Docket Text: Rule 7.1(d)(5) Letter for an automatic extension of the return date of a dispositive motion re [26] MOTION to Dismiss . (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Oct 5, 2021 | N/A | Set Motion, Evidentiary, R&R and Social Security Oral Arguments Deadlines/Hearings (0) Docket Text: Set Deadlines as to [26] MOTION to Dismiss . Motion set for 11/1/2021 before Judge Stanley R. Chesler. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Oct 4, 2021 | 26 | Main Document (3) Docket Text: MOTION to Dismiss by All Defendants. Responses due by 10/18/2021 (Attachments: # (1) Declaration of Arnold B. Calmann in support of Defendants' Motion to Dismiss, # (2) Text of Proposed Order, # (3) Certificate of Service)(CALMANN, ARNOLD) [Transferred from New Jersey on 3/9/2022.] |
| Oct 4, 2021 | 26 | Declaration of Arnold B. Calmann in support of Defendants' Motion to Dismis (46) |
| Oct 4, 2021 | 26 | Text of Proposed Order (2) |
| Oct 4, 2021 | 26 | Certificate of Service (2) |
| Sep 30, 2021 | N/A | Order (0) Docket Text: TEXT ORDER: The Court is in receipt of Plaintiff's letter request of 9/23/21 filed in Civil Action No. 21-10057 (ECF No. 29) and in Civil Action No. 21-10403 (ECF No. 18 ) to consolidate both civil actions, the MSN Defendants' response of 9/29/21 (Civ. A. No. 21-10057 at ECF No. 34), and the Mylan Defendants' objection of 9/26/21 (Civ. A. No. 21-10403 at ECF No. 19). Plaintiff's letter request is DENIED WITHOUT PREJUDICE subject to renewal by formal Motion after a decision on the Mylan Defendants' anticipated Motion to Dismiss. So Ordered by Magistrate Judge Jessica S. Allen on 9/30/21. (jbb) [Transferred from New Jersey on 3/9/2022.] |
| Sep 28, 2021 | N/A | Notice (Other) (0) Docket Text: Pro Hac Vice counsel, NICOLE W. STAFFORD, DENNIS D. GREGORY, ADEN M. ALLEN, STEPHANIE CHENG and JENNIFER A. WARD, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Sep 27, 2021 | 20 | Notice (Other) (2) Docket Text: Notice of Request by Pro Hac Vice Nicole W. Stafford to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-12837504.) (CALMANN, ARNOLD) [Transferred from New Jersey on 3/9/2022.] |
| Sep 27, 2021 | 21 | Notice (Other) (2) Docket Text: Notice of Request by Pro Hac Vice Dennis D. Gregory to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-12837594.) (CALMANN, ARNOLD) [Transferred from New Jersey on 3/9/2022.] |
| Sep 27, 2021 | 22 | Notice (Other) (2) Docket Text: Notice of Request by Pro Hac Vice Aden M. Allen to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-12837607.) (CALMANN, ARNOLD) [Transferred from New Jersey on 3/9/2022.] |
| Sep 27, 2021 | 23 | Notice (Other) (2) Docket Text: Notice of Request by Pro Hac Vice Stephanie Cheng to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-12837621.) (CALMANN, ARNOLD) [Transferred from New Jersey on 3/9/2022.] |
| Sep 27, 2021 | 24 | Notice (Other) (2) Docket Text: Notice of Request by Pro Hac Vice Jennifer A. Ward to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-12837636.) (CALMANN, ARNOLD) [Transferred from New Jersey on 3/9/2022.] |
| Sep 26, 2021 | 19 | Main Document (3) Docket Text: Letter from Defendants Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC, Mylan Inc., Viatris Inc., and Mylan Pharmaceuticals Inc. to Judge Chesler and Judge Allen re [18] Letter. (Attachments: # (1) Exhibit A)(CALMANN, ARNOLD)[Transferred from New Jersey on 3/9/2022.] |
| Sep 26, 2021 | 19 | Exhibit A (6) |
| Sep 23, 2021 | 18 | Main Document (3) Docket Text: Letter from William P. Deni, Jr. to the Honorable Stanley R. Chesler, U.S.D.J. and the Honorable Jessica S. Allen, U.S.M.J. re: consolidation. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(DENI, WILLIAM)[Transferred from New Jersey on 3/9/2022.] |
| Sep 23, 2021 | 18 | Exhibit A (3) |
| Sep 23, 2021 | 18 | Exhibit B (15) |
| Sep 23, 2021 | 18 | Exhibit C (8) |
| Sep 22, 2021 | 17 | Order (3) Docket Text: ORDER granting [15] Application for the Pro Hac Vice Admission of Nicole W. Stafford, Dennis D. Gregory, Aden M. Allen, Stephanie Cheng and Jennifer A. Ward. etc. Signed by Magistrate Judge Jessica S. Allen on 9/22/2021. (ams, ) Modified on 9/28/2021 (ams, ). [Transferred from New Jersey on 3/9/2022.] |
| Sep 21, 2021 | 15 | Main Document (3) Docket Text: APPLICATION/PETITION for Pro Hac Vice Admission of Cocounsel and Certification of Arnold B. Calmann in support of same for by AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC.. (Attachments: # (1) Declaration of Nicole W. Stafford in support of pro hac vice admission, # (2) Declaration of Dennis D. Gregory in support of pro hac vice admission, # (3) Declaration of Aden M. Allen in support of pro hac vice admission, # (4) Declaration of Stephanie Cheng in support of pro hac vice admission, # (5) Declaration of Jennifer A. Ward in support of pro hac vice admission, # (6) Text of Proposed Order, # (7) Certificate of Service)(CALMANN, ARNOLD)[Transferred from New Jersey on 3/9/2022.] |
| Sep 21, 2021 | 15 | Declaration of Nicole W. Stafford in support of pro hac vice admission (4) |
| Sep 21, 2021 | 15 | Declaration of Dennis D. Gregory in support of pro hac vice admission (4) |
| Sep 21, 2021 | 15 | Declaration of Aden M. Allen in support of pro hac vice admission (4) |
| Sep 21, 2021 | 15 | Declaration of Stephanie Cheng in support of pro hac vice admission (3) |
| Sep 21, 2021 | 15 | Declaration of Jennifer A. Ward in support of pro hac vice admission (3) |
| Sep 21, 2021 | 15 | Text of Proposed Order (3) |
| Sep 21, 2021 | 15 | Certificate of Service (2) |
| Sep 21, 2021 | 16 | Letter (2) Docket Text: Letter from Defendants Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC, Mylan Inc., Viatris Inc., and Mylan Pharmaceuticals Inc. to Magistrate Judge Allen re [15] Application/Petition,,. (HALPERN, JAKOB)[Transferred from New Jersey on 3/9/2022.] |
| Aug 18, 2021 | 14 | Order (1) Docket Text: CONSENT ORDER that the time within which Defendants may answer, move or otherwise respond to Plaintiffs Complaint is hereby extended through and including 10/4/2021. Signed by Magistrate Judge Jessica S. Allen on 8/18/2021. (bt, )[Transferred from New Jersey on 3/9/2022.] |
| Aug 17, 2021 | 10 | Main Document (2) Docket Text: Letter from defendants Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC, Mylan Inc., Viatris Inc., and Mylan Pharmaceuticals Inc. to Magistrate Judge Allen. (Attachments: # (1) Text of Proposed Order)(HALPERN, JAKOB)[Transferred from New Jersey on 3/9/2022.] |
| Aug 17, 2021 | 10 | Text of Proposed Order (1) |
| Aug 17, 2021 | 11 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by ARNOLD B. CALMANN on behalf of AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC. (CALMANN, ARNOLD) [Transferred from New Jersey on 3/9/2022.] |
| Aug 17, 2021 | 12 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by JAKOB BENJAMIN HALPERN on behalf of AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC. (HALPERN, JAKOB) [Transferred from New Jersey on 3/9/2022.] |
| Aug 17, 2021 | 13 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by CATHERINE MAGDY SOLIMAN on behalf of AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC. (SOLIMAN, CATHERINE) [Transferred from New Jersey on 3/9/2022.] |
| Jul 22, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC.. AGILA SPECIALTIES INC. waiver sent on 7/6/2021, answer due 9/7/2021; MYLAN API US LLC waiver sent on 7/6/2021, answer due 9/7/2021; MYLAN INC. waiver sent on 7/6/2021, answer due 9/7/2021; MYLAN PHARMACEUTICALS INC. waiver sent on 7/6/2021, answer due 9/7/2021; VIATRIS INC. waiver sent on 7/6/2021, answer due 9/7/2021. (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Jul 22, 2021 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC.. MYLAN LABORATORIES LTD. waiver sent on 7/6/2021, answer due 10/4/2021. (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Jul 8, 2021 | 6 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by BRYAN C. DINER on behalf of BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. (DINER, BRYAN) [Transferred from New Jersey on 3/9/2022.] |
| Jul 8, 2021 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by JUSTIN JAMES HASFORD on behalf of BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. (HASFORD, JUSTIN) [Transferred from New Jersey on 3/9/2022.] |
| Apr 29, 2021 | 4 | * (2) Docket Text: SUMMONS ISSUED as to AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC., VIATRIS INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Apr 29, 2021 | 5 | Main Document (1) Docket Text: AO120 Patent/Trademark Form filed. (Attachments: # (1) Complaint and Exhibits) (ams, ) [Transferred from New Jersey on 3/9/2022.] |
| Apr 29, 2021 | 5 | Complaint and Exhibits (777) |
| Apr 28, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Stanley R. Chesler and Magistrate Judge Jessica S. Allen. (ak, ) [Transferred from New Jersey on 3/9/2022.] |
| Apr 28, 2021 | 1 | Main Document (43) Docket Text: COMPLAINT against AGILA SPECIALTIES INC., MYLAN API US LLC, MYLAN INC., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. A VIATRIS COMPANY, VIATRIS INC. ( Filing and Admin fee $ 402 receipt number ANJDC-12418962), filed by BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) L. Civ. R. 11.2 & 40.1 Certification)(DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Apr 28, 2021 | 1 | Exhibit A (23) |
| Apr 28, 2021 | 1 | Exhibit B (23) |
| Apr 28, 2021 | 1 | Exhibit C (25) |
| Apr 28, 2021 | 1 | Exhibit D (139) |
| Apr 28, 2021 | 1 | Exhibit E (133) |
| Apr 28, 2021 | 1 | Exhibit F (127) |
| Apr 28, 2021 | 1 | Exhibit G (137) |
| Apr 28, 2021 | 1 | Exhibit H (124) |
| Apr 28, 2021 | 1 | Civil Cover Sheet (1) |
| Apr 28, 2021 | 1 | L. Civ. R. 11.2 & 40.1 Certification (2) |
| Apr 28, 2021 | 2 | Corporate Disclosure Statement (1) Docket Text: Corporate Disclosure Statement by BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC.. (DENI, WILLIAM) [Transferred from New Jersey on 3/9/2022.] |
| Apr 28, 2021 | 3 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. (LOWER, J.) [Transferred from New Jersey on 3/9/2022.] |
